Wenquan Zhuang

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0002-6384-2489

发表论文 58 篇 · 总被引 1055 次 · h-index 15

代表论文

• Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) (2022 · Journal of Clinical Oncology · 被引 452)
• Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study (2021 · Journal of Cancer Research and Clinical Oncology · 被引 114)
• Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score‐matching cohort study (2019 · JGH Open · 被引 31)
• Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study (2023 · Journal of Hepatocellular Carcinoma · 被引 24)
• Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study (2020 · Technology in Cancer Research & Treatment · 被引 23)
• Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy (2020 · Investigational New Drugs · 被引 17)